See highlights from GHTC's 2023 Innovating for Impact Awards

Search the GHTC website

Voices of Global Health - Stewart Parker, IDRI

Read time:
Infectious Disease Research Institute

In this guest post, Stewart Parker, CEO of the Infectious Disease Research Institute (IDRI), discusses working in Washington State’s global health community. IDRI, a GHTC member, conducts research and development for products to prevent, detect, and treat infectious diseases of poverty. This post originally appeared on the Washington Global Health Alliance’s Voices of Global Health blog to mark Global Health Month.

July 4, 2012 by Stewart Parker

In this guest post, Stewart Parker, CEO of the Infectious Disease Research Institute (IDRI), discusses working in Washington State’s global health community. IDRI, a GHTC member, conducts research and development for products to prevent, detect, and treat infectious diseases of poverty. This post originally appeared on the Washington Global Health Alliance’s Voices of Global Health blog to mark Global Health Month.

Stewart Parker is CEO of the Infectious Disease Research Institute

What sparked your interest in global health?

I’ve always loved being in biotech for the opportunity to both do good and do well. Global health is the ultimate step for me; I get to spend every day of the week helping to solve seemingly intractable disease problems! What could be better than that?

What three words would you use to describe Washington State’s global health community?

COLLABORATIVE. VIBRANT. FUN

What do you think is the best way for individuals to contribute to Washington’s global health work?

First, educate yourself. Global health problems affect all of us, so don’t be an ostrich! Second, do a little research and find an organization that you like…and support it. There are lots of volunteer opportunities, in addition to donating money. Third, spread the word. If you learn about a project or an organization that you like, help be an ambassador for that effort.

What is the greatest joy in your work?

The people. Working with smart people, meeting our partners in countries affected by neglected disease, and meeting people who are benefiting from our products.

What is the greatest challenge in your work?

I always want progress to occur faster than it does! Developing vaccines is a difficult challenge, and it takes time to do studies that are rigorous and support the movement of the vaccine product through the clinical trial process. I always want to do things with the highest standards, and we always will. But the timelines are sometimes frustrating.

Categories: Guest post

About the author

Stewart ParkerInfectious Disease Research Institute

Stewart Parker is CEO of the Infectious Disease Research Institute, nonprofit biotech organization taking a comprehensive approach to develop new solutions for infectious diseases.

Other Breakthroughs Blog posts you may like:
PATH/Gabe Bienczycki
July 9, 2012

Research Roundup: What We’re Reading This Week

Written by Kim Lufkin / GHTC
Read time:
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week. Results from a study published in the Lancet and presented at the XIX International AIDS Conference indicate that a novel tuberculosis combination drug may be on the horizon. The World Health Organization has endorsed the use of the antiretroviral drug Truvada for HIV prevention among HIV-negative people considered at a high risk. The US Food and Drug Administration has granted fast-track designation for Idenix Pharmaceuticals' drug candidate to treat hepatitis C. Drug maker Sanofi said its experimental vaccine against dengue fever proved safe and effective in a study in 4,000 children in Thailand, raising prospects for the first-ever vaccine against the disease after decades of research. The results of scientific research that addresses global health diseases and other issues will become freely available as part of the UK government's plans to open up access to publicly funded studies.
PATH/Gabe Bienczycki
June 28, 2012

Research Roundup: What We’re Reading this Week

Written by Kim Lufkin / GHTC
Read time:
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week. A recent article in VOA News reveals that a research team at Monash University has discovered a viral protein that may be used to develop an alternative to antibiotics. In a recent study in Nature Genetics, researchers say they have unraveled the genetic codes of four parasite strains responsible for the bulk of malaria cases outside Africa. The findings could have implications for malaria vaccine research and development. The military’s Defense Advanced Research Projects Agency has announced a new program to speed the development of a tool that integrates 10 human “organs-on-a-chip” to study complex human physiology outside the body. The international development network site Devex provides a sneak peek at the plans for the International AIDS Conference scheduled for 2014 in Melbourne, Australia. Researchers and policymakers recently gathered in London to champion affordable, innovative solutions to the world’s biggest health issues, such as maternal health.The meeting stemmed from a new partnership between the Qatar Foundation and Imperial College London.